The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by ...
Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback